Description
Have you got patients with hypothyroid symptoms but normal results? Or results that suggest the HPT axis just seems to be broken? Could it be the result of a combination of Endocrine Disrupting Chemicals (EDCs)? How do you assess for these ‘new goitrogens’, which act more potently and more insidiously, inducing hypothyroidism ‘without a trace’. How do you maximise prevention for all of your clients and the most at risk sub-populations or minimise impact for those already in the full grip of their consequences.
This audio comes with 3 key related scientific articles and a bonus larger powerpoint presentation that Rachel presented at ASLM Conference in Sydney.
Did you know you can subscribe to these? Become an Update in Under 30 Subscriber and save $$ and receive every month the latest research and access to the entire UU30 library of over 100+ episodes. Find out more here.
